Guminski, A., Foley, P., Grob, J.-J., Robert, C., Gutzmer, R. ., Squittieri, N., & Kiecker, F. (2023). Biochemistry laboratory shift based on common terminology criteria in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study. SKIN The Journal of Cutaneous Medicine, 7(2), s181. https://doi.org/10.25251/skin.7.supp.181